FDA Approved: WEZLANA — Supplemental Application (Nuvaila Limited)

View source ↗

Summary

The FDA approved a supplemental Biologics License Application for WEZLANA (ustekinumab-auub) submitted by Nuvaila Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• WEZLANA (USTEKINUMAB-AUUB)

Snippet

SUPPL AP for WEZLANA (USTEKINUMAB-AUUB)